NDC 63323-481-01 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-481
- Requested NDC
- 63323-481-01
- Package NDCs from labels
- 63323-481-01, 63323-481-57
- Manufacturer
- Henry Schein, Inc
- Effective date
- 2025-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine - Henry Schein, Inc | Henry Schein, Inc | 2025-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-481-01 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-481-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-481 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 2 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-481-57 | ML - Milliliter | 63323-481 | 27e8b3c9-2007-4f4b-ba9e-56cc304eebbf | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | cffda6fc-7e85-4c48-9623-2551d3552d7d | 2026-04-24 | Warnings, Adverse reactions | 1010033 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 7f202319-effa-4dd8-b871-e720b75f4a83 | 2026-04-23 | Warnings, Adverse reactions | 1737757 1737761 1737562 1737566 1737568 EC2CNF7XFP |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| AKTEN | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Thea Pharma Inc. | 70ff9fb7-d323-4fe6-b1b1-6033e05f0749 | 2026-04-23 | Warnings, Adverse reactions | EC2CNF7XFP |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | 1ca96c77-d983-496b-84a6-54709e80f532 | 2026-04-23 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | f8d90500-f797-4238-8dd2-b59cbcd89d12 | 2026-04-23 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Sportpharm LLC | 2c58deba-dbb2-4e73-a173-36053536f03e | 2026-04-22 | Warnings, Adverse reactions | 1010751 |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 7adb9ab0-ef91-4c51-baa3-a0b7e12df077 | 2026-04-21 | Warnings, Adverse reactions | 1010033 |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | c3490a23-14c4-43f7-b066-96a4c4298fde | 2026-04-14 | Warnings, Adverse reactions | 1010751 |
| SODIUM CHLORIDE 1 GRAM | SODIUM CHLORIDE | Gendose Pharmaceuticals, LLC | ce988ae5-61c6-4324-90e1-a94c8a54d0d0 | 2026-04-13 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.